白蛋白尿作为心力衰竭系统性淤血的标志物
结果显示白蛋白尿与更严重的淤血表现及淤血相关生物标志物升高独立相关,聚类分析表明白蛋白尿更多聚集于淤血标志物而非肾功能指标。
要点
- 白蛋白尿与心衰患者淤血的临床、超声及循环生物标志物一致相关
- 白蛋白尿与死亡及心衰再住院风险增加相关
- 微量白蛋白尿患病率35.4%,大量白蛋白尿患病率10.0%
核心结论
- 在新发或 worsening 心衰患者中,白蛋白尿与淤血的临床、超声心动图及循环生物标志物一致相关。
主要发现
- 微量白蛋白尿和大量白蛋白尿患病率分别为35.4%和10.0%。
- 白蛋白尿患者心衰更严重,表现为住院期间入选、NYHA功能分级更高、淤血体征症状更多及淤血相关生物标志物(生物活性肾上腺髓质素、CA125、NT-proBNP)浓度更高(均P<0.001)。
- 白蛋白尿与死亡和心衰(再)住院风险增加相关(两个队列一致)。
- log UACR与log NT-proBNP独立关联最强(标准化回归系数0.438,95%CI 0.35–0.53,P<0.001)。
- 层次聚类分析显示UACR与淤血标志物聚集,而与肾功能指标聚集较少。
关键数值与推荐
- 微量白蛋白尿定义为尿白蛋白肌酐比(UACR)30 mg/gCr,大量白蛋白尿定义为300 mg/gCr( spot urines)。
临床怎么用
- 在心衰患者中,白蛋白尿可作为系统性淤血的简易标志物,辅助评估淤血严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Albuminuria is common in patients with heart failure and associated with worse outcomes. The underlying pathophysiological mechanism of albuminuria in heart failure is still incompletely understood. The association of clinical characteristics and biomarker profile with albuminuria in patients with heart failure with both reduced and preserved ejection fractions were evaluated. METHODS AND RESULTS: Two thousand three hundred and fifteen patients included in the index cohort of BIOSTAT-CHF were evaluated and findings were validated in the independent BIOSTAT-CHF validation cohort (1431 patients). Micro-albuminuria and macro-albuminuria were defined as urinary albumincreatinine ratio (UACR) 30 mg/gCr and 300 mg/gCr in spot urines, respectively. The prevalence of micro- and macro-albuminuria was 35.4 and 10.0, respectively. Patients with albuminuria had more severe heart failure, as indicated by inclusion during admission, higher New York Heart Association functional class, more clinical signs and symptoms of congestion, and higher concentrations of biomarkers related to congestion, such as biologically active adrenomedullin, cancer antigen 125, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) (all P 0.001). The presence of albuminuria was associated with increased risk of mortality and heart failure (re)hospitalization in both cohorts. The strongest independent association with log UACR was found for log NT-proBNP (standardized regression coefficient 0.438, 95 confidence interval 0.350.53, P 0.001). Hierarchical clustering analysis demonstrated that UACR clusters with markers of congestion and less with indices of renal function. The validation cohort yielded similar findings. CONCLUSION: In patients with new-onset or worsening heart failure, albuminuria is consistently associated with clinical, echocardiographic, and circulating biomarkers of congestion.
引用
- Boorsma, Ter Maaten, Damman, et al. Albuminuria as a marker of systemic congestion in patients with heart failure. Eur Heart J. 2023. PMID: 36148485. doi:10.1093/eurheartj/ehac528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。